(NewsDirect)
ContactDetails
Proactive Investors USA
ProactiveInvestors USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2022 TheNewswire - All rights reserved.
(NewsDirect)
Proactive Investors USA
ProactiveInvestors USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2022 TheNewswire - All rights reserved.
Market Wire News is a media platform, the information on this page was provided by TheNewsWire via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Context Therapeutics Inc. Company Name:
CNTX Stock Symbol:
Market:
Context Therapeutics Inc. Website:
Announced FDA clearance of IND application for a Phase 1 clinical trial of CTIM-76 Completed $100 million financing; expected to extend funding into 2028 PHILADELPHIA, May 08, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...